Bright Minds Biosciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2019
Period Ending	Mar '26 Mar 9, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	2020 - 2019
Market Capitalization	1,005	598	7	8	28	107	Upgrade
Market Cap Growth	176.56%	9016.50%	-19.09%	-71.17%	-73.71%	-	Upgrade
Enterprise Value	916	547	0	0	19	85	Upgrade
Last Close Price	102.71	84.39	1.47	2.15	8.50	45.20	Upgrade
PB Ratio	11.26	7.29	1.19	1.23	2.67	5.51	Upgrade
P/TBV Ratio	11.26	7.29	1.19	1.23	2.67	5.52	Upgrade
Debt / Equity Ratio	0.00	0.00	0.02	0.01	0.01	-	Upgrade
Net Debt / Equity Ratio	-1.00	-1.01	-1.01	-1.01	-1.09	-1.02	Upgrade
Quick Ratio	56.59	35.68	10.92	24.16	8.00	31.12	Upgrade
Current Ratio	57.37	36.10	11.32	24.26	8.11	31.38	Upgrade
Return on Equity (ROE)	-26.98%	-27.93%	-46.18%	-86.02%	-99.95%	-85.94%	Upgrade
Return on Assets (ROA)	-15.72%	-18.80%	-25.28%	-47.45%	-57.32%	-51.52%	Upgrade
Return on Capital Employed (ROCE)	-21.00%	-16.60%	-47.10%	-109.10%	-138.80%	-44.40%	Upgrade
Earnings Yield	-1.97%	-2.04%	-42.70%	-90.90%	-53.20%	-8.09%	Upgrade
Buyback Yield / Dilution	-48.78%	-59.58%	-15.87%	-50.58%	-37.64%	-148.42%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.